Literatuurreferenties
1. IB-tekst lanthaancarbonaat (Fosrenol®) via: www.cbg-meb.nl, Geneesmiddeleninformatiebank.
2. Hutchison AJ, et al. Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate. Nephron Clin Pract 2005; 100: c8-19.
3. Hutchison AJ, et al. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study. Nephron Clin Pract 2006; 102: c61-c71.
4. CFH-rapport lanthaancarbonaat (Fosrenol®), via: www.cvz.nl, CFH-rapporten.
